Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
growth hormone
|
| gptkbp:activeDuring |
somatropin
|
| gptkbp:administrativeDivision |
daily
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:availableIn |
generic version
|
| gptkbp:brand |
Genotropin_GoQuick
Genotropin_MiniQuick |
| gptkbp:clinicalTrials |
long-term treatment
for adult growth hormone deficiency for chronic kidney disease for pediatric growth hormone deficiency replacement therapy for_Prader-Willi_syndrome for_Turner_syndrome |
| gptkbp:contraindication |
diabetes
active malignancy hypersensitivity to somatropin severe obesity |
| gptkbp:dosageForm |
vial
|
| gptkbp:formFactor |
injectable solution
|
| gptkbp:hasPopulation |
children
adults |
| https://www.w3.org/2000/01/rdf-schema#label |
Genotropin
|
| gptkbp:interactsWith |
glucocorticoids
estrogens antidiabetic medications |
| gptkbp:is_monitored_by |
growth rate
thyroid function blood glucose IGF-1 levels |
| gptkbp:launchSite |
upper arm
thigh abdomen |
| gptkbp:mandates |
short stature
|
| gptkbp:marketedAs |
gptkb:Canada
gptkb:European_Union gptkb:United_States |
| gptkbp:patentExpiration |
2023
|
| gptkbp:producedBy |
gptkb:Pfizer
|
| gptkbp:route |
subcutaneous injection
|
| gptkbp:shelfLife |
up to 28 days after opening
|
| gptkbp:sideEffect |
muscle pain
swelling joint pain headaches |
| gptkbp:storage |
refrigerated
|
| gptkbp:triggerType |
stimulates growth
increases protein synthesis promotes lipolysis |
| gptkbp:usedFor |
growth hormone deficiency
|